technology & science•Sun, August 23, 2026•4 min read

The Startup Keeping Human Skin Alive for Weeks to Train AI

Outer Biosciences has emerged from stealth with a breakthrough platform that keeps surgically discarded human skin viable for a month. By training AI on real biological responses, the company aims to revolutionize how we discover new cosmetic and pharmaceutical ingredients.

A New Frontier in Biological Data

For years, the cosmetic and pharmaceutical industries have relied on a limited toolkit: animal models, simplified cell cultures, or lab-grown organoids. These proxies often fail to capture the complexity of human biology, leading to a bottleneck in innovation. Now, Outer Biosciences, a startup founded in 2022 by Michael Polansky, is attempting to change that by using real, living human skin as the primary training ground for artificial intelligence.

How It Works: Life Beyond the Body

Outer Biosciences has developed a proprietary perfusion and bioreactor system that can keep surgically discarded human skin tissue alive and biologically active for up to a month. While traditional skin samples used in research typically degrade within days, this extended viability allows researchers—and their AI models—to observe long-term biological processes like collagen remodeling, pigmentation, and barrier repair.

Outer Biosciences uses advanced bioreactor technology to sustain human skin for weeks of research.

AI-Driven Ingredient Discovery

The company’s platform, YUNA, does not rely on public datasets. Instead, it feeds on data generated from high-throughput experiments where thousands of potential compounds are applied to living tissue. Computer vision tracks cellular changes in real-time, while transcriptomic and proteomic data are processed by foundation models to identify novel mechanisms of action.

Tissue Viability: Skin samples are kept alive for four weeks, far longer than standard lab models.
Data Quality: AI is trained on raw biological responses rather than historical, static research papers.
Speed: The platform generates a new candidate ingredient roughly every six weeks.
Business Model: Outer Biosciences plans to license its discovered ingredients to beauty and pharma partners rather than launching a consumer-facing brand.

Most skincare 'innovation' recombines the same limited set of molecules. Our platform was built to do something different: identify genuinely new mechanisms of action, and the compounds that drive them, in biology that behaves like real human skin.
— Outer Biosciences

Key Takeaways

Outer Biosciences has raised approximately $23 million to advance its AI-powered ingredient discovery.
The startup keeps human skin viable for weeks using specialized bioreactor technology.
The AI model learns from real-time biological data, bypassing the limitations of animal and lab-grown models.
Six lead compounds are currently in the pipeline, with four expected to reach commercialization.
The company focuses on licensing its discoveries to industry partners rather than direct-to-consumer sales.

FAQ

Where does the skin used in Outer Biosciences' research come from?

The company obtains de-identified human skin that has been discarded during surgical procedures through established tissue banks and brokers.

Why is keeping skin alive for a month important?

Standard skin models degrade within days, which limits the ability to study long-term biological responses like inflammation, aging, and deep tissue repair.

Is Outer Biosciences launching a new skincare brand?

No. The company acts as a discovery platform and intends to license its AI-discovered ingredients to existing beauty and pharmaceutical companies.

How does the AI model learn?

The AI is trained on real-time data from automated, high-throughput experiments, using computer vision and proteomic data captured from the living tissue samples.